ImmuSmol is sponsoring the Symposium “The immune-brain axis: from molecules to behavior”, held at the Hasselt University, Campus Diepenbeek, Belgium, on March 12th and 13th, 2015.
Read moreDiscover ImmuSmol’s story, featured in the 2015 winter edition of the European Biotechnology Magazine.
Read moreJust a few words to thank our clients and partners and wish them a bright and joyful 2015.
Read moreImmuSmol is pleased to announce it has raised 500 000 € to progress its monoclonal antibodies for cancer immunotherapy to in vivo proof-of-concept (POC).
Read moreAccess latest article by ImmuSmol CEO Alban Bessède
Read moreNEW! ImmuSmol releases rabbit polyclonal antibodies against Tryptophan / Kynurenine metabolites, all validated for IHC in human samples.
Picture: L-Kynurenine detection by IHC in human colorectal cancer tissue using anti-L-Kynurenine rabbit pAb.
ImmuSmol will be in Turin for Bioeurope Spring 2014, on March 10-12. Contact us to arrange a meeting!
Read moreA short overview of ImmuSmol’s services for the development of antibodies against small molecules, and their subsequent validation for small molecule detection by ELISA or IHC.
Read moreSmall molecule antibodies constitute a powerful alternative to mass spec and aptamer-based technologies for small molecule detection, building on the advantages of existing immunodetection methods such as ELISA and IHC. Overview…
Read moreA brief overview of ImmuSmol’s antibody development services for the detection of small molecules in biological samples…
Read moreContact
us